Raymond James Financial Services Advisors, Inc. Abb Vie Inc. Call Options Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

Call Options

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $13,197 - $16,375	-100 Reduced 0.28%	36,000 $121,000
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $204,117 - $258,267	-1,900 Reduced 5.0%	36,100 $49,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $439,890 - $484,266	-4,300 Reduced 10.17%	38,000 $8,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $1.47 Million - $1.99 Million	18,300 Added 76.25%	42,300 $56,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $1.85 Million - $2.18 Million	24,000 New	24,000 $3,000

Others Institutions Holding ABBV

# of Institutions

3,869

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $302B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account